Patent Assignment
Reel/Frame 017706/0515
Assignment of Assignor's Interest
Recorded: 2006-05-31
Pages: 2
Assignor
NANOGEN POINT OF CARE INC.
Executed: 2006-05-16
Assignee
NANOGEN INC.
10398 PACIFIC CENTER COURT, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Inter-Alpha Trypsin Inhibitor Biopolymer Marker Indicative of Insulin Resistance
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
Security Interest
Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Change of Name
May 19, 2006
From: SYN X PHARMA INC.
To: NANOGEN POINT OF CARE INC.
Reel/Frame 017656/0059 →
Assignment of Intellectual Property Security Agreement
Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest
Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →
Grant of Security Interest
Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →